2023 - Research.com Neuroscience in United States Leader Award
2010 - J. Allyn Taylor International Prize in Medicine, Robarts Research Institute
Charles DeCarli focuses on Internal medicine, Dementia, Alzheimer's disease, Pathology and Cardiology. Charles DeCarli is interested in Stroke, which is a field of Internal medicine. The study incorporates disciplines such as Psychiatry, Cognition, Cognitive impairment and Gerontology in addition to Dementia.
His study in Alzheimer's disease is interdisciplinary in nature, drawing from both Nuclear medicine, Neuroimaging, Neuroscience, Cognitive decline and Atrophy. The concepts of his Pathology study are interwoven with issues in Diabetes mellitus, Hyperintensity and Central nervous system disease. Charles DeCarli combines subjects such as Cerebral infarction, Brain morphometry, Corpus callosum, Frontal lobe and Blood pressure with his study of Cardiology.
Internal medicine, Dementia, Cardiology, Cognition and Hyperintensity are his primary areas of study. His Internal medicine study integrates concerns from other disciplines, such as Magnetic resonance imaging and Pathology. In his study, Disease is strongly linked to Neuroimaging, which falls under the umbrella field of Magnetic resonance imaging.
The various areas that Charles DeCarli examines in his Dementia study include Alzheimer's disease, Psychiatry, Gerontology and Cohort. He has included themes like Diabetes mellitus, Surgery, Blood pressure and Brain size in his Cardiology study. His studies deal with areas such as White matter and Audiology as well as Hyperintensity.
His main research concerns Internal medicine, Dementia, Cognition, Cohort and Disease. His Internal medicine research integrates issues from Hyperintensity and Cardiology. In his study, which falls under the umbrella issue of Dementia, Hazard ratio is strongly linked to Biomarker.
His studies in Cognition integrate themes in fields like Clinical psychology and Healthy aging. His Cohort research is multidisciplinary, relying on both Alzheimer's disease, Cohort study, Gerontology and Ethnically diverse. His Disease research incorporates themes from Neuroimaging and Etiology.
His primary areas of investigation include Internal medicine, Dementia, Cognition, Magnetic resonance imaging and Framingham Heart Study. His Internal medicine research includes elements of Brain size and Cardiology. His Dementia research is multidisciplinary, incorporating elements of Framingham Risk Score, Incidence, Biomarker, Prospective cohort study and Cohort.
His biological study spans a wide range of topics, including Evolutionary biology, Disease, Cortex and Cognitive decline. He is studying Hyperintensity, which is a component of Magnetic resonance imaging. His Framingham Heart Study research incorporates elements of Stroke and Cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Vascular dementia Diagnostic criteria for research studies: Report of the NINDS‐AIREN International Workshop*
Gustavo C. Roman;T. K. Tatemichi;T. Erkinjuntti;J. L. Cummings.
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.
B. Winblad;K. Palmer;Miia Kivipelto;V. Jelic.
Journal of Internal Medicine (2004)
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
Joanna M. Wardlaw;Eric E. Smith;Geert J Biessels;Charlotte Cordonnier.
Lancet Neurology (2013)
Vascular Contributions to Cognitive Impairment and Dementia A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Philip B. Gorelick;Angelo Scuteri;Sandra E. Black;Charles Decarli.
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.
Clifford R. Jack;Matt A. Bernstein;Nick C. Fox;Paul Thompson.
Journal of Magnetic Resonance Imaging (2008)
Vascular Cognitive Impairment
John T O'Brien;Timo Erkinjuntti;Barry Reisberg;Gustavo Roman.
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
Vladimir Hachinski;Costantino Iadecola;Ron C. Petersen;Monique M. Breteler.
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang.
Nature Genetics (2011)
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline.
S. Debette;S. Seshadri;S. Seshadri;A. Beiser;A. Beiser;R. Au;R. Au.
Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment.
Lancet Neurology (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: